Lung tissue from COVID-19 patients and others reveals promising target to treat lung fibrosis

(American Association for the Advancement of Science) An analysis of lung tissues from patients with different types of pulmonary fibrosis - including cases triggered by COVID-19 - has revealed a promising molecular target to ameliorate the chronic and irreversible disease. Experiments in mouse models of lung fibrosis showed that administering blockers of